London and Berlin-based startup Medbelle has raised €6m in Series A funding to speed up development of its “end-to-end” patient care platform. The round was led by signals Venture Capital, with participation from Talis Capital, Mutschler Ventures, IBB Beteiligungsgesellschaft and Cavalry Ventures, according to a statement.
Medbelle describes its offering as a “three-layered ‘digital hospital’” - through the Medbelle Platform, Medbelle Care and Medbelle Operating System - that puts patients in charge of their care and helps them navigate a “fragmented” health care sector. It also aims to support professionals access a suite of management tools covering patients’ entire treatment journey.
“Major digital platforms improve customer experience in almost all industries, however, in healthcare, the digitisation of patient journeys has been heavily lagging behind until now. Medbelle’s technology and personalised care enable much simpler and more affordable medical treatments - while allowing healthcare providers to efficiently focus on treating patients,” said Clemens Koós, investment manager at signals Venture Capital.
30,000 patients in the UK have reportedly already used Medbelle's services
In the launch phase, Medbelle initially focused on privately-paid procedures in the cosmetics, bariatrics and ophthalmology areas. The startup says it has already helped over 30,000 patients across the UK, and is now expanding into orthopaedics and fertility treatment.
“The new capital will accelerate the development of our platform while growing Medbelle’s operating footprint,” said Medbelle MD and co-founder Daniel Kolb. “It will allow us to streamline high-quality care at scale and take even more work off the hospitals’ and specialists’ shoulders. Our technology helps them to operate more efficiently, be better-utilised and fully focused on what matters most: the best care for patients.”
Announcing the new funding, the startup also said it had plans to work with the NHS and private and public health insurers in the future to offer its services to cover “all types of medical procedures”.
“The digital health market is expected to reach $536bn [around €474bn] by 2025 – so the time is right to be focusing on technologies that can transform healthcare and the patient journey as we know it today,” said Talis Capital managing partner Vasile Foca. “We’re proud to be backing Leander [de Laporte], Daniel [co-founders] and their high-quality team in this latest round as they roll out their truly digital treatment solution,” Foca added.
